We are pleased to announce that VAC4EU and the SIGMA Consortium have formally joined forces and expressed our shared vision and a mutual goal to continue collaborating, developing existing synergies, and sharing expertise and knowledge, information, and tools developed by the two networks for pharmacoepidemiology/real-world evidence studies and activities.
SIGMA Consortium is a contract-based alliance of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) research centers launched on 11th November 2011. It is being launched to enable multi-country studies using common analyses to study responses to treatments in large populations, and to clarify and quantify these treatment effects for the citizens of Europe.
Back to collaborations